News

LinkGevity is among a cluster of biotech firms in Cambridge working on potential longevity treatments. They include clock.bio ...
Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include ...
Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...
A 2019 study found that every two hours in the US, a child was taken to hospital because of accidental exposure to cosmetic ...
July 25, 2025 - Government and private funding for genomic research is the key factor driving market revenue growth. According to the Alzheimer’s Dis ...